Tryptophan derivatives as non‐invasive diagnostic indicators for obesity‐related MASLD in children and adolescents
Diabetes, Obesity and Metabolism · 2025-12 · 27 (12) · 7544-7560
DOI: 10.1111/dom.70162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 01.10.2025. Verfasst von Shumin Zhan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzho…. Hauptthemen laut MEDLINE: Tryptophan, Pediatric Obesity, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Research Fund of National Health Commission & Zhejiang major Health Science and Technology.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aims
Metabolic dysfunction‐associated steatotic liver disease (MASLD) represents a major health burden in children and adolescents with obesity. This study aimed to characterize metabolic alterations associated with obesity‐related MASLD and to evaluate the potential of tryptophan (TRP)‐derived metabolites as non‐invasive biomarkers for early diagnosis. Materials and Methods A total of 30 normal‐weight individuals and 80 patients diagnosed with obesity were included in the discovery cohort. Circulating metabolites were quantified and compared among normal‐weight individuals, patients with obesity, and those with obesity‐related MASLD to identify metabolic changes associated with disease status. In vitro experiments using mouse hepatocytes and liver organoids were conducted to assess the effects of TRP‐derived metabolites on intracellular lipid accumulation. Finally, a non‐invasive diagnostic model was developed using machine learning techniques and validated in an independent cohort of 112 individuals.
Results
Circulating TRP metabolism was markedly elevated in children and adolescents with obesity‐related MASLD compared with both normal‐weight controls and individuals with simple obesity. TRP‐derived metabolites significantly promoted intracellular lipid accumulation in mouse hepatocytes and liver organoids via the induction of oxidative stress. The non‐invasive diagnostic model based on TRP‐derived metabolites demonstrated robust performance in differentiating obesity‐related MASLD from simple obesity in both the discovery and validation cohorts.
Discussion
These findings highlight the pivotal role of TRP metabolism in the pathogenesis of MASLD in children and adolescents with obesity. Elevated TRP‐derived metabolites may contribute to hepatic lipid accumulation through oxidative stress and serve as promising non‐invasive biomarkers for the early diagnosis of obesity‐related MASLD. The machine learning–based diagnostic model offers a practical and less invasive alternative to current diagnostic approaches such as liver biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Key Laboratory for Translational Research and Innovative Therapeutics of Gastrointestinal Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Clinical Research Center, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Pediatrics, The First Affliated Hospital of Nanjing Medical University, Nanjing, China.
- School of Cyberspace Security, Southeast University, Nanjing, China.
ORCID-Profile: Bowen Zhu, Junfen Fu, Xirong Guo
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Research Fund of National Health Commission & Zhejiang major Health Science and Technology
Zitieren
APA
Zhan, S., Wang, X., Wang, C., Zhu, B., Gao, J., Peng, Z., Wang, R., Yang, Y., Zhang, L., Wang, T., Wu, J., Wu, W., Huang, K., Dong, G., Ren, Q., Wang, S., Wang, S., Zhou, X., Xu, L., …, & Guo, X. (2025). Tryptophan derivatives as non‐invasive diagnostic indicators for obesity‐related MASLD in children and adolescents. Diabetes, Obesity and Metabolism, 27(12), 7544-7560. https://doi.org/10.1111/dom.70162
Vancouver
Zhan S, Wang X, Wang C, Zhu B, Gao J, Peng Z, et al. Tryptophan derivatives as non‐invasive diagnostic indicators for obesity‐related MASLD in children and adolescents. Diabetes, Obesity and Metabolism. 2025;27(12):7544-7560. doi:10.1111/dom.70162
BibTeX
@article{Zhan2025,
author = {Zhan, Shumin and Wang, Xingyun and Wang, Chen and Zhu, Bowen and Gao, Jianfang and Peng, Zhou and Wang, Rui and Yang, Yun and Zhang, Liang and Wang, Tengfei and Wu, Jiaoxiang and Wu, Wei and Huang, Ke and Dong, Guanping and Ren, Qiannan and Wang, Shan and Wang, Senjie and Zhou, Xuelian and Xu, Liling and Fu, Junfen and Guo, Xirong},
title = {Tryptophan derivatives as non‐invasive diagnostic indicators for obesity‐related MASLD in children and adolescents},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {12},
pages = {7544--7560},
doi = {10.1111/dom.70162}
}
EUVIMED